TerminatedPHASE2, PHASE3NCT00228371

STIMEP : Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy

Studying Metabolic diseases with epilepsy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Grenoble
Principal Investigator
Stephan CHABARDES, Dr
University Hospital of Grenoble, Neuro surgery
Intervention
Neurostimulation(device)
Enrollment
4 enrolled
Eligibility
18-50 years · All sexes
Timeline
20052010

Study locations (3)

Collaborators

Ministry of Health, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00228371 on ClinicalTrials.gov

Other trials for Metabolic diseases with epilepsy

Additional recruiting or active studies for the same condition.

See all trials for Metabolic diseases with epilepsy

← Back to all trials